Home / Angiotensin II / Belgium
BE ATC C01CX09 · updated 2 Nov 2026
Angiotensin II shortage in Belgium
Is there an Angiotensin II shortage in Belgium?
Yes. As of 2 Nov 2026, 1 Angiotensin II product is reported short in Belgium, the first since 3 Mar 2026. The company estimate for the return is 14 Jul 2027. Main reason: active ingredient shortage.
Not reported short in any other country we track. All countries.
Affected products in Belgium
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| BE | Giapreza 2.5 mg/ml inf. sol. (conc.) i.v. vial 10 x 1 ml | Paion Pharma | 3 Mar 2026 | 14 Jul 2027 | Active ingredient shortage Active Substance not available |
Source
FAMHP (Federal Agency for Medicines and Health Products), PharmaStatus / SAMv2. Official list. All authorised packs with a declared temporary unavailability.